174 related articles for article (PubMed ID: 10486203)
21. GSK-3beta directly phosphorylates and activates MARK2/PAR-1.
Kosuga S; Tashiro E; Kajioka T; Ueki M; Shimizu Y; Imoto M
J Biol Chem; 2005 Dec; 280(52):42715-22. PubMed ID: 16257959
[TBL] [Abstract][Full Text] [Related]
22. Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos.
He X; Saint-Jeannet JP; Woodgett JR; Varmus HE; Dawid IB
Nature; 1995 Apr; 374(6523):617-22. PubMed ID: 7715701
[TBL] [Abstract][Full Text] [Related]
23. Association of protein kinase FA/GSK-3alpha (a proline-directed kinase and a regulator of protooncogenes) with human cervical carcinoma dedifferentiation/progression.
Yang SD; Yu JS; Lee TT; Ni MH; Yang CC; Ho YS; Tsen TZ
J Cell Biochem; 1995 Oct; 59(2):143-50. PubMed ID: 8904308
[TBL] [Abstract][Full Text] [Related]
24. Characterization of tau phosphorylation in glycogen synthase kinase-3beta and cyclin dependent kinase-5 activator (p23) transfected cells.
Michel G; Mercken M; Murayama M; Noguchi K; Ishiguro K; Imahori K; Takashima A
Biochim Biophys Acta; 1998 Apr; 1380(2):177-82. PubMed ID: 9565682
[TBL] [Abstract][Full Text] [Related]
25. Sites of phosphorylation in tau and factors affecting their regulation.
Anderton BH; Betts J; Blackstock WP; Brion JP; Chapman S; Connell J; Dayanandan R; Gallo JM; Gibb G; Hanger DP; Hutton M; Kardalinou E; Leroy K; Lovestone S; Mack T; Reynolds CH; Van Slegtenhorst M
Biochem Soc Symp; 2001; (67):73-80. PubMed ID: 11447841
[TBL] [Abstract][Full Text] [Related]
26. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.
Zheng-Fischhöfer Q; Biernat J; Mandelkow EM; Illenberger S; Godemann R; Mandelkow E
Eur J Biochem; 1998 Mar; 252(3):542-52. PubMed ID: 9546672
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation of tau protein by recombinant GSK-3beta: pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain.
Godemann R; Biernat J; Mandelkow E; Mandelkow EM
FEBS Lett; 1999 Jul; 454(1-2):157-64. PubMed ID: 10413115
[TBL] [Abstract][Full Text] [Related]
28. Expression analysis of glycogen synthase kinase-3 in human tissues.
Lau KF; Miller CC; Anderton BH; Shaw PC
J Pept Res; 1999 Jul; 54(1):85-91. PubMed ID: 10448973
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of the mouse dishevelled-1 protein inhibits GSK-3beta-mediated phosphorylation of tau in transfected mammalian cells.
Wagner U; Brownlees J; Irving NG; Lucas FR; Salinas PC; Miller CC
FEBS Lett; 1997 Jul; 411(2-3):369-72. PubMed ID: 9271238
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of tau by glycogen synthase kinase 3beta in intact mammalian cells influences the stability of microtubules.
Sang H; Lu Z; Li Y; Ru B; Wang W; Chen J
Neurosci Lett; 2001 Oct; 312(3):141-4. PubMed ID: 11602330
[TBL] [Abstract][Full Text] [Related]
31. PTH induction of transcriptional activity of the cAMP response element-binding protein requires the serine 129 site and glycogen synthase kinase-3 activity, but not casein kinase II sites.
Tyson DR; Swarthout JT; Jefcoat SC; Partridge NC
Endocrinology; 2002 Feb; 143(2):674-82. PubMed ID: 11796524
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly.
Utton MA; Vandecandelaere A; Wagner U; Reynolds CH; Gibb GM; Miller CC; Bayley PM; Anderton BH
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):741-7. PubMed ID: 9169608
[TBL] [Abstract][Full Text] [Related]
33. Peptide substrates suitable for assaying glycogen synthase kinase-3 in crude cell extracts.
Welsh GI; Patel JC; Proud CG
Anal Biochem; 1997 Jan; 244(1):16-21. PubMed ID: 9025901
[TBL] [Abstract][Full Text] [Related]
34. Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain.
Hoshi M; Takashima A; Noguchi K; Murayama M; Sato M; Kondo S; Saitoh Y; Ishiguro K; Hoshino T; Imahori K
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2719-23. PubMed ID: 8610107
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of glycogen synthase kinase-3beta (GSK-3beta) protein expression during neuroblastoma IMR-32 cell differentiation.
Muñoz-Montaño JR; Moreno FJ; Avila J; Díaz-Nido J
J Neurosci Res; 1999 Feb; 55(3):278-85. PubMed ID: 10348658
[TBL] [Abstract][Full Text] [Related]
36. Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenes.
Brownlees J; Irving NG; Brion JP; Gibb BJ; Wagner U; Woodgett J; Miller CC
Neuroreport; 1997 Oct; 8(15):3251-5. PubMed ID: 9351652
[TBL] [Abstract][Full Text] [Related]
37. The function of the microtubule-associated protein tau is variably modulated by graded changes in glycogen synthase kinase-3beta activity.
Leroy K; Menu R; Conreur JL; Dayanandan R; Lovestone S; Anderton BH; Brion JP
FEBS Lett; 2000 Jan; 465(1):34-8. PubMed ID: 10620702
[TBL] [Abstract][Full Text] [Related]
38. tau kinases in the rat heat shock model: possible implications for Alzheimer disease.
Shanavas A; Papasozomenos SC
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14139-44. PubMed ID: 11121021
[TBL] [Abstract][Full Text] [Related]
39. Intracellular domains of amyloid precursor-like protein 2 interact with CP2 transcription factor in the nucleus and induce glycogen synthase kinase-3beta expression.
Xu Y; Kim HS; Joo Y; Choi Y; Chang KA; Park CH; Shin KY; Kim S; Cheon YH; Baik TK; Kim JH; Suh YH
Cell Death Differ; 2007 Jan; 14(1):79-91. PubMed ID: 16645641
[TBL] [Abstract][Full Text] [Related]
40. Association between glycogen synthase kinase-3beta genetic polymorphism and late-onset Alzheimer's disease.
Mateo I; Infante J; Llorca J; Rodríguez E; Berciano J; Combarros O
Dement Geriatr Cogn Disord; 2006; 21(4):228-32. PubMed ID: 16428884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
